Downs Christopher
- SEC CIK
- 0001705978
No open-market purchases or sales filed in the past year.
Current role at each company
- CNSP CNS Pharmaceuticals, Inc.Chief Financial Officeras of Nov 19, 2025
- CIK 0001829966Directoras of Feb 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Downs Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CNSP CNS Pharmaceuticals, Inc.
Chief Financial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 (view filing)10:27 AM ET | Feb 1 | 5 daysLate | Downs ChristopherChief Financial Officer | PPurchase | +66.7K | $0.30 | +$20.0K | +181.3%103.4K after | |
| Aug 23, 2023 (view filing) | Aug 22 | 1 day | Downs ChristopherChief Financial Officer | PPurchase | +27.0K | $1.27 | +$34.3K | +276.3%36.8K after | |
| Apr 18, 2023 (view filing) | Apr 17 | 1 day | Downs ChristopherChief Financial Officer | PPurchase | +3.10K | $3.20 | +$9.92K | +50.4%9.25K after | |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Downs ChristopherChief Financial Officer | PPurchase | +5.00K | $0.94 | +$4.70K | +3.4%151.5K after | |
| Nov 22, 2021 (view filing) | Nov 19 | 3 days | Downs ChristopherChief Financial Officer | PPurchase | +4.50K | $1.15 | +$5.17K | +3.2%146.5K after |